# HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
> **ANDA204765** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2017-03-06
## Drug
- **FDA Application Number:** ANDA204765
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
- **Generic name:** Homatropine Methylbromide
- **Active ingredients:** HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
- **Dosage form:** SYRUP
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SCIEGEN PHARMS
- **First approval:** 2017-03-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204765)
---
*AI Analytics · CC0 1.0*